No Data
No Data
Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30
Morgan Stanley analyst Vincent Andrews maintains $The Chemours(CC.US)$ with a hold rating, and maintains the target price at $30.According to TipRanks data, the analyst has a success rate of 66.4%
Chemours Announces Dates for Second Quarter 2024 Earnings Release and Webcast Conference Call
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The Company
Chemours to Benefit From Regulation on Refrigerants as Demand Improves, UBS Says
Chemours' (CC) low share valuation and conservative estimates are expected to pivot as earnings in TiO2 return to normal and demand for refrigerants improves by 2025, UBS said in a note Tuesday."We
Express News | Chemours Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $28 to $30
Chemours Price Target Raised to $30.00/Share From $28.00 by UBS
Chemours Price Target Raised to $30.00/Share From $28.00 by
Chemours Raised to Buy From Neutral by UBS
Chemours Raised to Buy From Neutral by